Published in J Urol on June 01, 1967
'Green revolution' genes encode mutant gibberellin response modulators. Nature (1999) 8.87
The Arabidopsis GAI gene defines a signaling pathway that negatively regulates gibberellin responses. Genes Dev (1997) 7.30
LNCaP model of human prostatic carcinoma. Cancer Res (1983) 7.23
Is the new veterinary college a good model? J Am Vet Med Assoc (1998) 5.86
Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer (1980) 3.37
Purification of a human prostate specific antigen. Invest Urol (1979) 3.11
Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease. N Engl J Med (1977) 2.94
Carcinoembryonic antigen in patients with different cancers. JAMA (1972) 2.56
Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin (1993) 2.43
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer (1998) 2.15
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology (1998) 2.04
American Joint Committee on Cancer prognostic factors consensus conference. Cancer (1999) 2.02
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology (1982) 1.99
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res (1988) 1.91
SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature (1971) 1.77
Race-related differences in breast cancer patients. Results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer (1985) 1.76
Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer (1981) 1.73
Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate (1999) 1.71
Secondary carcinomas of the kidney. J Urol (1975) 1.59
The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer (1999) 1.58
Clinical highlights from the National Cancer Data Base: 1994. CA Cancer J Clin (1994) 1.58
The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet (1984) 1.54
The diagnosis of acute acalculous cholecystitis: a comparison of sonography, scintigraphy, and CT. AJR Am J Roentgenol (1986) 1.50
Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli. J Gen Microbiol (1992) 1.48
The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment. Cancer (1997) 1.47
Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer (1994) 1.46
Radiometric estimation of the replication time of bacteria in culture: an objective and precise approach to quantitative microbiology. J Nucl Med (1978) 1.40
Sensitivity, specificity and predictive accuracy of radionuclide cineangiography during exercise in patients with coronary artery disease. Comparison with exercise electrocardiography. Circulation (1979) 1.40
The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer (1991) 1.39
Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage. Am Rev Respir Dis (1981) 1.35
Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer (1988) 1.35
CEA as a monitor of gastrointestinal malignancy. Cancer (1975) 1.33
The kinetics of 67gallium incorporation into inflammatory lesions: experimental and clinical studies. J Lab Clin Med (1974) 1.33
Granulomatous sarcoid nephritis. Am J Med (1967) 1.31
CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. J Surg Oncol (1998) 1.29
Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons. J Urol (1986) 1.29
Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons. Ann Surg (1980) 1.27
Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer. Cancer (1993) 1.27
The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer (1996) 1.25
The association of benign prostatic hyperplasia and cancer of the prostate. Cancer (1992) 1.22
Rapid migration of 111indium-labeled granulocytes to sites of infection. N Engl J Med (1981) 1.22
Prostate antigen: a new potential marker for prostatic cancer. Prostate (1981) 1.18
Exercise-induced left ventricular dysfunction in symptomatic and asymptomatic patients with aortic regurgitation: assessment with radionuclide cineangiography. Am J Cardiol (1978) 1.17
Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients. Prostate Suppl (1996) 1.17
Tissue signatures with dual-energy computed tomography. Radiology (1979) 1.13
The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer (1996) 1.13
Correlations of the orthogonal electrocardiogram and vectorcardiogram with consitutional variables in 518 normal men. Circulation (1967) 1.12
Follow-up evaluation of a phase II prostate cancer vaccine trial. Prostate (1999) 1.11
Use of human prostate-specific antigen in monitoring prostate cancer. Cancer Res (1981) 1.10
Why is the prostate cancer death rate declining in the United States? Cancer (1998) 1.09
A murine renal cell carcinoma. J Natl Cancer Inst (1973) 1.09
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. Prostate (1998) 1.09
A prostate antigen in sera of prostatic cancer patients. Cancer Res (1980) 1.08
Matrix metalloproteinase homologues from Arabidopsis thaliana. Expression and activity. J Biol Chem (1999) 1.07
Management and survival of carcinoma of the colon: results of a national survey by the American College of Surgeons. Ann Surg (1978) 1.07
Renal localization of gallium-67 citrate. Radiology (1975) 1.07
Ejection fraction by count rate from gated images. J Nucl Med (1978) 1.07
Prostate cancer: progress and change. CA Cancer J Clin (1978) 1.06
Localization of 197Hg chlormerodrin and sodium 131-I in the female reproductive tract. J Nucl Med (1968) 1.06
The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer. Cancer (1979) 1.05
A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program. Cancer (1997) 1.05
Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA Cancer J Clin (1993) 1.05
Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides. Prostate (1997) 1.05
Prostate-specific membrane antigen: current and future utility. Semin Urol Oncol (1998) 1.04
Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res (1980) 1.04
The National Cancer Data Base report on longitudinal observations on prostate cancer. Cancer (1996) 1.04
Prostate-specific antigen levels in young white and black men 20 to 45 years old. Urology (2000) 1.04
The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol (1982) 1.04
American Cancer Society guideline for the early detection of prostate cancer: update 1997. CA Cancer J Clin (1997) 1.04
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
Method for identifying prostate cells in semen using flow cytometry. Prostate (1998) 1.04
Resolution time of an amebic liver abscess. Gastroenterology (1968) 1.03
Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin. J Urol (1975) 1.03
Chemotherapy programs of the National Prostatic Cancer Project (NPCP). Cancer (1980) 1.03
ECG-gated scintillation probe measurement of left ventricular function. J Nucl Med (1977) 1.03
Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation. Invest Urol (1978) 1.03
Fibrin degradation products in renal parenchymal disease states and renal transplant patients. Transplantation (1972) 1.02
Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project. J Urol (1994) 1.02
Primary liver tumors and oral contraceptives. Results of a survey. JAMA (1977) 1.01
An assessment of the current use of human interferons in therapy of urological cancers. J Urol (1989) 1.01
Search for BK and SV40 virus reactivation in renal transplant recipients. Transplantation (1974) 1.01
Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial. Cancer Res (2000) 1.00
American Cancer Society guidelines for the early detection of prostate cancer: update, June 10, 1997. Cancer (1997) 1.00
Prostate antigen: a marker for human prostate epithelial cells. J Natl Cancer Inst (1981) 1.00
Posttraumatic cardiac dysfunction: assessment with radionuclide ventriculography. Radiology (1986) 1.00
Prostate cancer in blacks: an update from the American College of Surgeons' patterns of care studies. J Surg Oncol (1989) 1.00
Workgroup 4: spontaneous prostate carcinoma in dogs and nonhuman primates. Prostate (1998) 1.00
Revision in American Cancer Society recommendations for the early detection of colorectal cancer. CA Cancer J Clin (1992) 1.00
Cost analyses of prostate cancer screening: frameworks for discussion. Investigators of the American Cancer Society-National Prostate Cancer Detection Project. J Urol (1994) 1.00
"Normal" bone radionuclide image with diffuse skeletal lymphoma. A case report. Radiology (1974) 0.99
Hormonal therapy in advanced renal cell carcinoma. Cancer (1971) 0.98
Two new, direct, and specific methods of acid phosphatase determination. National field trial. Urology (1979) 0.98
Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990. J Am Coll Surg (1995) 0.98
Comparative medicine in medical education. J Am Vet Med Assoc (1974) 0.97
Management and survival of female patients with "minimal" breast cancer: as observed in the long-term and short-term surveys of the American College of Surgeons. Cancer (1981) 0.97